Pharmaceutical care program for patients with reactive airways disease

A pharmaceutical care program for patients with reactive airways disease (R AD) is described. A pharmaceutical care program for patients with RAD was developed and imple mented at: 36 CV pharmacies. The impact on patient outcomes, pharmacist job satisfaction, and other variables is currently being evaluated in a contro lled trial with more than 1100 patient enrollees. Guiding the program are t he beliefs that pharmacists must have clinically relevant, patient-specific data to provide appropriate care; that pharmacists must have adequate trai ning to provide pharmaceutical care; that the program must be sensitive to organizational barriers, particularly time demands; and that there must be ongoing support for the program. The program has five components: (1) compu ter display of patient-specific data for patients enrolled in the study, (2 ) distribution of tailored patient education materials, (3) use of a resour ce guide to facilitate the implementation of pharmaceutical care, (4) strat egies to reinforce and facilitate the program, and (5) pharmacist training. While developed for community pharmacies, the program is applicable to mos t ambulatory care pharmacy practices. A pharmaceutical care program for patients with RAD was developed for use i n community pharmacies.